Valeant Pharmaceuticals International Inc (NYSE:VRX)

17.33
Delayed Data
As of Apr 19
 -0.07 / -0.40%
Today’s Change
8.31
Today|||52-Week Range
24.43
-16.60%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Paulson & Co Inc
Director
Sale3/06/20187,066,629$15.40$108.8M+13.12%
Paulson & Co Inc
Director
Buy3/06/20187,066,629$15.40$108.8M+13.12%
Paulson & Co Inc
Director
Buy11/16/2017344,216$14.40$5.0M+20.85%
Paulson & Co Inc
Director
Sale11/16/2017344,216$14.39$5.0M+20.85%
Papa Joseph C
Chairman & Chief Executive Officer
Buy3/13/201830,000$16.05$481.5K+7.77%
Humphries William D
Chairman
Sale1/03/201814,730$20.78$306.1K-24.68%
De Schutter Richard U
Director
Buy5/11/201720,000$13.90$278.0K+25.58%
Herendeen Paul S
Chief Financial Officer & Executive Vice President
Sale8/23/201717,175$14.14$242.9K+20.18%
Herendeen Paul S
Chief Financial Officer & Executive Vice President
Buy3/13/201815,000$16.10$241.5K+7.77%
De Schutter Richard U
Director
Buy3/08/201810,000$15.34$153.4K+13.49%
Page of 6